Clinical trial
Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus
NCT00004643 is registered in ClinicalTrials.gov with National Center for Research Resources (NCRR) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus
- Lead sponsor
- National Center for Research Resources (NCRR)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 1995
- Completion date
- Not reported
- Enrollment
- 10
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.